{"id":"https://openalex.org/W1998148704","doi":"https://doi.org/10.1038/sj.bjc.6605726","title":"A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours","display_name":"A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W1998148704","doi":"https://doi.org/10.1038/sj.bjc.6605726","mag":"1998148704","pmid":"https://pubmed.ncbi.nlm.nih.gov/20588278","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2905291"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6605726","doi":"https://doi.org/10.1038/sj.bjc.6605726","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605726","pdf_url":"https://www.nature.com/articles/6605726.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6605726.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077199450","display_name":"Ulrik Lassen","orcid":"https://orcid.org/0000-0002-3865-4574","observed_orcids":["https://orcid.org/0000-0002-3865-4574"]},"institutions":[{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"U Lassen","raw_affiliation_strings":["Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark. ulrik.lassen@rh.regionh.dk","Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark. ulrik.lassen@rh.regionh.dk","institution_ids":["https://openalex.org/I2802567020","https://openalex.org/I2802709434"]},{"raw_affiliation_string":"Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013897432","display_name":"L. Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L R Molife","raw_affiliation_strings":["Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070373312","display_name":"Morten Mau\u2010S\u00f8rensen","orcid":"https://orcid.org/0000-0003-2235-1250","observed_orcids":["https://orcid.org/0000-0003-2235-1250"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"M Sorensen","raw_affiliation_strings":["Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005376969","display_name":"S A Engelholm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"S-A Engelholm","raw_affiliation_strings":["Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University Hospital, Rigshospitalet, Copenhagen 2100, Denmark,","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101520157","display_name":"Laura Vidal","orcid":"https://orcid.org/0000-0001-7519-3319","observed_orcids":["https://orcid.org/0000-0001-7519-3319"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Vidal","raw_affiliation_strings":["Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R Sinha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Sinha","raw_affiliation_strings":["Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089955620","display_name":"Richard T. Penson","orcid":"https://orcid.org/0000-0002-8091-8588","observed_orcids":["https://orcid.org/0000-0002-8091-8588"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R T Penson","raw_affiliation_strings":["Department of Haematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, 02114, MA, USA","Department of Haematology/Oncology, Massachusetts General Hospital, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, 02114, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Haematology/Oncology, Massachusetts General Hospital, Boston, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064336901","display_name":"Peter Buhl-Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Buhl-Jensen","raw_affiliation_strings":["TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050812177","display_name":"Elizabeth M. Crowley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Crowley","raw_affiliation_strings":["TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076521860","display_name":"Jette Tj\u00f8rnelund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Tjornelund","raw_affiliation_strings":["TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023421349","display_name":"Poul Knoblauch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Knoblauch","raw_affiliation_strings":["TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TopoTaget A/S, Symbion Science Park, Fruebjergvej 3, Copenhagen 2100, Denmark,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J S de Bono","raw_affiliation_strings":["Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Institute of Cancer Research, The Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5077199450"],"corresponding_institution_ids":["https://openalex.org/I2802567020","https://openalex.org/I2802709434"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":3.7751,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.94243666,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"103","issue":"1","first_page":"12","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belinostat","display_name":"belinostat","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9800000190734863},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5289999842643738},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7549999952316284},{"id":"https://openalex.org/keywords/rectal-cancer","display_name":"rectal cancer","score":0.718999981880188},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/ca-125-response","display_name":"CA-125 response","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.9252028465270996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8821059465408325},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8299634456634521},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6650159358978271},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.643866777420044},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5492222905158997},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.46778735518455505},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.44759681820869446},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4461188316345215},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.44592300057411194},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.43811553716659546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42197397351264954},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41625893115997314},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.39867711067199707},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3722469210624695},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3320387899875641},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.2142665982246399},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1824943721294403},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/sj.bjc.6605726","doi":"https://doi.org/10.1038/sj.bjc.6605726","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605726","pdf_url":"https://www.nature.com/articles/6605726.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2118500","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2905291","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2905291","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2905291","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:20588278","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20588278","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/4bb0530f-d85d-48aa-871f-136ded87f422","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/4bb0530f-d85d-48aa-871f-136ded87f422","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lassen, U, Molife, L R, Sorensen, J M, Engelholm, S-A, Vidal, L, Sinha, R, Penson, R T, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, J S & Buhl-Jensen, P 2010, 'A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours', B J C, vol. 103, no. 1, pp. 12-7. https://doi.org/10.1038/sj.bjc.6605726","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6605726","doi":"https://doi.org/10.1038/sj.bjc.6605726","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605726","pdf_url":"https://www.nature.com/articles/6605726.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998148704.pdf","grobid_xml":"https://content.openalex.org/works/W1998148704.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1511815964","https://openalex.org/W1949662878","https://openalex.org/W1967018540","https://openalex.org/W1991376723","https://openalex.org/W2003907016","https://openalex.org/W2013981808","https://openalex.org/W2020278966","https://openalex.org/W2022285476","https://openalex.org/W2025220605","https://openalex.org/W2050931169","https://openalex.org/W2053495438","https://openalex.org/W2099030380","https://openalex.org/W2116996913","https://openalex.org/W2118535812","https://openalex.org/W2139248078","https://openalex.org/W2139375162","https://openalex.org/W2142629029","https://openalex.org/W2144679758","https://openalex.org/W2153696028","https://openalex.org/W2162438863","https://openalex.org/W2169409181","https://openalex.org/W2171185186"],"related_works":["https://openalex.org/W7100267866","https://openalex.org/W2243735979","https://openalex.org/W2142629029","https://openalex.org/W2346100223","https://openalex.org/W2973034045","https://openalex.org/W2009053040","https://openalex.org/W2562853903","https://openalex.org/W2169409181","https://openalex.org/W2421095347","https://openalex.org/W2140723571"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"phase":[2],"I":[3],"study":[4],"assessed":[5],"the":[6,22,26,59,73,76,172],"maximum":[7],"tolerated":[8],"dose,":[9],"dose-limiting":[10],"toxicity":[11],"(DLT)":[12],"and":[13,19,21,120,158,167,183],"pharmacokinetics":[14,163],"of":[15,25,33,43,75,90,104,164,193,223,228],"belinostat":[16,44,77,91,105],"with":[17,40,92,115,220],"carboplatin":[18,56,93,121,168],"paclitaxel":[20,64,116,166],"anti-tumour":[23,229],"activity":[24,230],"combination":[27,216],"in":[28],"solid":[29],"tumours.":[30],"METHODS:":[31],"Cohorts":[32],"three":[34],"to":[35],"six":[36,203],"patients":[37,83,204],"were":[38,68,132,169,176],"treated":[39],"escalating":[41],"doses":[42],"administered":[45,69,102,124],"intravenously":[46],"once":[47],"daily,":[48],"days":[49,113],"1-5":[50],"q21":[51],"days;":[52],"on":[53,125],"day":[54,89,111,126],"3,":[55],"(area":[57],"under":[58],"curve":[60],"(AUC)":[61],"5)":[62],"and/or":[63,94],"(175":[65,117],"mg":[66,86,108,118],"m(-2))":[67,119],"2-3":[70],"h":[71],"after":[72],"end":[74],"infusion.":[78],"RESULTS:":[79],"In":[80,201],"all":[81],"23":[82],"received":[84],"600-1000":[85],"m(-2)":[87,109],"per":[88,110],"paclitaxel.":[95],"No":[96],"DLT":[97],"was":[98,106,217],"observed.":[99],"The":[100,162,215],"maximal":[101],"dose":[103],"1000":[107],"for":[112],"1-5,":[114],"AUC":[122],"5":[123],"3.":[127],"Grade":[128],"III/IV":[129],"adverse":[130],"events":[131],"(n;":[133],"%):":[134],"leucopenia":[135],"(5;":[136],"22%),":[137],"neutropenia":[138],"(7;":[139],"30%),":[140],"thrombocytopenia":[141],"(3;":[142],"13%)":[143],"anaemia":[144],"(1;":[145,153,156,160],"4%),":[146,154],"peripheral":[147],"sensory":[148],"neuropathy":[149],"(2;":[150],"9%),":[151],"fatigue":[152],"vomiting":[155],"4%)":[157],"myalgia":[159],"4%).":[161],"belinostat,":[165],"unaltered":[170],"by":[171],"concurrent":[173],"administration.":[174],"There":[175],"two":[177],"partial":[178],"responses":[179],"(one":[180],"rectal":[181],"cancer":[182],"one":[184],"pancreatic":[185],"cancer).":[186],"A":[187],"third":[188],"patient":[189],"(mixed":[190],"mullerian":[191],"tumour":[192],"ovarian":[194],"origin)":[195],"showed":[196,205],"a":[197,206],"complete":[198],"CA-125":[199],"response.":[200],"addition,":[202],"stable":[207],"disease":[208],"lasting":[209],">":[210],"or":[211],"=6":[212],"months.":[213],"CONCLUSION:":[214],"well":[218],"tolerated,":[219],"no":[221],"evidence":[222],"pharmacokinetic":[224],"interaction.":[225],"Further":[226],"evaluation":[227],"is":[231],"warranted.":[232]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}